|
|
||||||||
The Journal of Immunology, Vol 147, Issue 12 4207-4210, Copyright © 1991 by American Association of Immunologists
ARTICLES |
AC van Dinther-Janssen, E Horst, G Koopman, W Newmann, RJ Scheper, CJ Meijer and ST Pals
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Lymphocyte migration to inflammatory sites is an essential factor in the pathogenesis of chronic inflammation. An ensemble of adhesion receptors mediating lymphocyte-endothelial cell recognition and binding are thought to play a crucial role in this process. In the present study, we have explored the molecular basis of lymphocyte adhesion to endothelium in the synovial membrane of patients with rheumatoid arthritis. We established that the very late antigen-4 [VLA-4 (CD49d)] and the vascular cell adhesion molecule-1 (VCAM-1) are important mediators of binding to synovial endothelium of resting and, to a greater extent, of activated T lymphocytes, whereas the leukocyte- function associated antigen-1 [LFA-1 (CD11a/18)]/intercellular adhesion molecule-1 [ICAM-1 (CD54)] pathway is less important in this interaction. In contrast to its prominent role in lymphocyte interaction with endothelium in rheumatoid synovium, the VLA-4/VCAM-1 pathway does not significantly contribute to lymphocyte adhesion to peripheral lymph node high endothelial venule. Thus, the VLA-4/VCAM-1 pathway may be of primary importance in mediating lymphocyte adhesion to inflamed endothelium and in lymphocyte homing to rheumatoid synovium.
This article has been cited by other articles:
![]() |
W. Li, K. Ishihara, T. Yokota, T. Nakagawa, N. Koyama, J. Jin, Y. Mizuno-Horikawa, X. Wang, E. Miyoshi, N. Taniguchi, et al. Reduced {alpha}4 1 Integrin/VCAM-1 Interactions Lead to Impaired Pre-B Cell Repopulation in Alpha 1,6-Fucosyltransferase Deficient Mice Glycobiology, January 1, 2008; 18(1): 114 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Batra, A. C. Smith, J. Feehally, and J. Barratt T-cell homing receptor expression in IgA nephropathy Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2540 - 2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Orito, M. Fujimoto, N. Ishiura, K. Yanaba, T. Matsushita, M. Hasegawa, F. Ogawa, K. Takehara, and S. Sato Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus reaction J. Leukoc. Biol., May 1, 2007; 81(5): 1197 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Minami, M. Miura, W. C. Aird, and T. Kodama Thrombin-induced Autoinhibitory Factor, Down Syndrome Critical Region-1, Attenuates NFAT-dependent Vascular Cell Adhesion Molecule-1 Expression and Inflammation in the Endothelium J. Biol. Chem., July 21, 2006; 281(29): 20503 - 20520. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Koni, S. K. Joshi, U.-A. Temann, D. Olson, L. Burkly, and R. A. Flavell Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice: Impaired Lymphocyte Migration to Bone Marrow J. Exp. Med., March 19, 2001; 193(6): 741 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C Kraan, M D Smith, H Weedon, M J Ahern, F C Breedveld, and P P Tak Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis Ann Rheum Dis, March 1, 2001; 60(3): 296 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamann and U. Syrbe T-cell trafficking into sites of inflammation Rheumatology, July 1, 2000; 39(7): 696 - 699. [Full Text] [PDF] |
||||
![]() |
P. Drillenburg and S. T. Pals Cell adhesion receptors in lymphoma dissemination Blood, March 15, 2000; 95(6): 1900 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitani, N. Nakashima, T. Izumihara, M. Inagaki, X. Baoui, S. Yu, T. Matsuda, and T. Matsuyama Soluble VCAM-1 Induces Chemotaxis of Jurkat and Synovial Fluid T Cells Bearing High Affinity Very Late Antigen-4 J. Immunol., November 1, 1998; 161(9): 4931 - 4938. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Pacheco, M. Tarkowski, J. Klemm, and L. J. Rosenwasser CD49d Expression and Function on Allergen-stimulated T Cells from Blood and Airway Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 286 - 293. [Abstract] [Full Text] |
||||
![]() |
L Kwee, H. Baldwin, H. Shen, C. Stewart, C Buck, C. Buck, and M. Labow Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice Development, January 2, 1995; 121(2): 489 - 503. [Abstract] [PDF] |
||||
![]() |
M. May, G Entwistle, M. Humphries, and A Ager VCAM-1 is a CS1 peptide-inhibitable adhesion molecule expressed by lymph node high endothelium J. Cell Sci., January 9, 1993; 106(1): 109 - 119. [Abstract] [PDF] |
||||
![]() |
J. C. M. Morel, C. C. Park, J. M. Woods, and A. E. Koch A Novel Role for Interleukin-18 in Adhesion Molecule Induction through NFkappa B and Phosphatidylinositol (PI) 3-Kinase-dependent Signal Transduction Pathways J. Biol. Chem., September 28, 2001; 276(40): 37069 - 37075. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |